Related Experiment Video
Updated: Apr 5, 2026
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
[Modern Nanomedicine in Treatment of Lung Carcinomas]
Backgrounds:
Despite the fast development of new effective cytostatics and targeted therapy, the treatment efficiency of lung cancer is still insufficient. The systemic administration of drugs results in a decrease in drug concentrations in tumor site, particularly due to specific extracellular environment in lungs. Nanotransporters could serve as a platform, protecting a drug against these undesired effects, which may enhance its therapeutic index and reduce side effects of a drug. Moreover, nanotechnologies possess the potential to improve the diagnostics of lung cancer, and thus increase a survival rate of oncologic patients.
Aim:
The presented study is aimed to demonstrate the possibilities provided by nanotechnologies in the field of treatment and diagnostic of lung cancers and discuss the obstacles, which complicate a translation into clinical practice.
Insights
Nanotechnology offers promising solutions for lung cancer treatment and diagnostics. By protecting drugs and improving delivery, nanotransporters can enhance therapeutic effectiveness and reduce side effects, improving patient outcomes.
Area of Science:
- Nanomedicine
- Biotechnology
- Oncology
Context:
- Lung cancer treatment remains challenging despite advances in chemotherapy and targeted therapies.
- Systemic drug administration leads to suboptimal drug concentrations at the tumor site due to the lung's extracellular environment.
- Nanotechnology presents a novel approach to overcome these limitations in lung cancer therapy.
Purpose:
- To explore the potential of nanotechnologies in enhancing lung cancer treatment and diagnostics.
- To discuss the challenges hindering the clinical application of nanomedicine in oncology.
Summary:
- Nanotransporters can protect therapeutic agents from degradation and improve their delivery to lung tumors.
- This approach aims to increase drug concentration at the tumor site, enhancing the therapeutic index.
- Nanodiagnostics hold potential for earlier and more accurate detection of lung cancer, improving patient survival rates.
Impact:
- Nanomedicine can significantly improve the efficacy of lung cancer therapies.
- Enhanced drug delivery via nanotransporters may reduce systemic toxicity and side effects.
- Advancements in nanodiagnostics can lead to improved lung cancer detection and patient prognosis.
